vs

Side-by-side financial comparison of NexPoint Real Estate Finance, Inc. (NREF) and RAPID MICRO BIOSYSTEMS, INC. (RPID). Click either name above to swap in a different company.

RAPID MICRO BIOSYSTEMS, INC. is the larger business by last-quarter revenue ($11.3M vs $11.1M, roughly 1.0× NexPoint Real Estate Finance, Inc.). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -110.8%, a 327.4% gap on every dollar of revenue. On growth, RAPID MICRO BIOSYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs -48.8%).

NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.

Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.

NREF vs RPID — Head-to-Head

Bigger by revenue
RPID
RPID
1.0× larger
RPID
$11.3M
$11.1M
NREF
Growing faster (revenue YoY)
RPID
RPID
+86.1% gap
RPID
37.3%
-48.8%
NREF
Higher net margin
NREF
NREF
327.4% more per $
NREF
216.6%
-110.8%
RPID

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NREF
NREF
RPID
RPID
Revenue
$11.1M
$11.3M
Net Profit
$24.0M
$-12.5M
Gross Margin
Operating Margin
-108.2%
Net Margin
216.6%
-110.8%
Revenue YoY
-48.8%
37.3%
Net Profit YoY
58.7%
-29.3%
EPS (diluted)
$0.47
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NREF
NREF
RPID
RPID
Q4 25
$11.1M
$11.3M
Q3 25
$12.5M
$7.8M
Q2 25
$12.1M
$7.3M
Q1 25
$11.5M
$7.2M
Q4 24
$21.7M
$8.2M
Q3 24
$12.5M
$7.6M
Q2 24
$6.7M
$6.6M
Q1 24
$-12.8M
$5.6M
Net Profit
NREF
NREF
RPID
RPID
Q4 25
$24.0M
$-12.5M
Q3 25
$50.9M
$-11.5M
Q2 25
$22.3M
$-11.9M
Q1 25
$26.0M
$-11.3M
Q4 24
$15.2M
$-9.7M
Q3 24
$23.3M
$-11.3M
Q2 24
$12.1M
$-12.6M
Q1 24
$-14.6M
$-13.3M
Operating Margin
NREF
NREF
RPID
RPID
Q4 25
-108.2%
Q3 25
-145.1%
Q2 25
-167.3%
Q1 25
-161.8%
Q4 24
-124.5%
Q3 24
-158.3%
Q2 24
-202.1%
Q1 24
-254.4%
Net Margin
NREF
NREF
RPID
RPID
Q4 25
216.6%
-110.8%
Q3 25
407.0%
-146.8%
Q2 25
184.5%
-163.3%
Q1 25
225.6%
-156.3%
Q4 24
69.9%
-117.6%
Q3 24
186.4%
-148.9%
Q2 24
179.7%
-190.1%
Q1 24
114.3%
-237.4%
EPS (diluted)
NREF
NREF
RPID
RPID
Q4 25
$0.47
$-0.26
Q3 25
$1.14
$-0.26
Q2 25
$0.54
$-0.27
Q1 25
$0.70
$-0.26
Q4 24
$0.71
$-0.22
Q3 24
$0.74
$-0.26
Q2 24
$0.40
$-0.29
Q1 24
$-0.83
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NREF
NREF
RPID
RPID
Cash + ST InvestmentsLiquidity on hand
$31.1M
$20.0M
Total DebtLower is stronger
$771.2M
Stockholders' EquityBook value
$388.0M
$33.2M
Total Assets
$5.3B
$74.9M
Debt / EquityLower = less leverage
1.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NREF
NREF
RPID
RPID
Q4 25
$31.1M
$20.0M
Q3 25
$17.9M
$18.9M
Q2 25
$9.1M
$18.3M
Q1 25
$19.2M
$18.9M
Q4 24
$3.9M
$16.9M
Q3 24
$34.7M
$22.0M
Q2 24
$4.3M
$37.1M
Q1 24
$13.5M
$22.4M
Total Debt
NREF
NREF
RPID
RPID
Q4 25
$771.2M
Q3 25
$720.9M
Q2 25
$815.6M
Q1 25
$831.5M
Q4 24
$799.3M
Q3 24
$815.5M
Q2 24
$861.0M
Q1 24
$843.3M
Stockholders' Equity
NREF
NREF
RPID
RPID
Q4 25
$388.0M
$33.2M
Q3 25
$375.4M
$44.3M
Q2 25
$348.2M
$54.5M
Q1 25
$343.7M
$65.5M
Q4 24
$336.5M
$75.4M
Q3 24
$335.8M
$84.4M
Q2 24
$327.5M
$94.6M
Q1 24
$327.1M
$105.9M
Total Assets
NREF
NREF
RPID
RPID
Q4 25
$5.3B
$74.9M
Q3 25
$5.3B
$84.4M
Q2 25
$5.4B
$75.6M
Q1 25
$5.4B
$85.4M
Q4 24
$5.4B
$98.2M
Q3 24
$5.7B
$105.8M
Q2 24
$6.6B
$117.1M
Q1 24
$7.1B
$127.7M
Debt / Equity
NREF
NREF
RPID
RPID
Q4 25
1.99×
Q3 25
1.92×
Q2 25
2.34×
Q1 25
2.42×
Q4 24
2.38×
Q3 24
2.43×
Q2 24
2.63×
Q1 24
2.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NREF
NREF
RPID
RPID
Operating Cash FlowLast quarter
$-4.5M
$-3.2M
Free Cash FlowOCF − Capex
$-3.3M
FCF MarginFCF / Revenue
-29.6%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
-0.19×
TTM Free Cash FlowTrailing 4 quarters
$-31.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NREF
NREF
RPID
RPID
Q4 25
$-4.5M
$-3.2M
Q3 25
$8.1M
$-9.1M
Q2 25
$3.3M
$-9.7M
Q1 25
$16.0M
$-9.1M
Q4 24
$4.4M
$-9.9M
Q3 24
$14.7M
$-8.6M
Q2 24
$-7.5M
$-10.1M
Q1 24
$17.7M
$-15.5M
Free Cash Flow
NREF
NREF
RPID
RPID
Q4 25
$-3.3M
Q3 25
$-9.1M
Q2 25
$-10.1M
Q1 25
$-9.4M
Q4 24
$-10.0M
Q3 24
$-8.8M
Q2 24
$-10.6M
Q1 24
$-16.1M
FCF Margin
NREF
NREF
RPID
RPID
Q4 25
-29.6%
Q3 25
-116.4%
Q2 25
-138.6%
Q1 25
-130.2%
Q4 24
-121.8%
Q3 24
-116.0%
Q2 24
-159.8%
Q1 24
-287.1%
Capex Intensity
NREF
NREF
RPID
RPID
Q4 25
0.8%
Q3 25
0.9%
Q2 25
5.0%
Q1 25
4.4%
Q4 24
1.2%
Q3 24
2.9%
Q2 24
6.9%
Q1 24
10.4%
Cash Conversion
NREF
NREF
RPID
RPID
Q4 25
-0.19×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.62×
Q4 24
0.29×
Q3 24
0.63×
Q2 24
-0.62×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NREF
NREF

Segment breakdown not available.

RPID
RPID

Products$9.3M83%
Services$2.0M17%

Related Comparisons